NexMed, Inc. (NASDAQ: NEXM), a developer of innovative pharmaceutical products based on its proprietary NexACT® transdermal drug delivery technology, announced that the Company intends to file its Form 10-K for year ended December 31, 2005 today. Management will host a conference call tomorrow, Friday, March 17, 2006 at 9:00a.m. (EST) to discuss these results and to provide a Company update.
